ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Prior notification of a concentration

(Case M.10923 – PLASTIC OMNIUM / HBPO)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 381/05)

1. On 23 September 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Compagnie Plastic Omnium SE (‘Plastic Omnium’, France), controlled by Burelle SA (France), — HBPO Beteiligungsgesellschaft mbH (‘HBPO’, Germany), currently jointly controlled by Plastic Omnium and Hella GmbH & Co. KGaA (Germany). Plastic Omnium will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of HBPO. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — Plastic Omnium operates globally as an automotive Tier-1 supplier, specialised in the development, manufacture and supply of components and modules/systems, mainly for light vehicles (mainly bumpers, hatchbacks/tailgates and spoilers, fuel storage and delivery systems fuel cell stacks and hydrogen vessels and integrated hydrogen systems), — HBPO develops, manufactures and supplies, for light vehicles, front-end carriers, active grille shutters, module solutions for vehicle interiors (cockpits and centre consoles), solutions for electric vehicle charging as well as developing, assembling and supplying front-end modules.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10923 – PLASTIC OMNIUM / HBPO Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10902 – FEV CONSULTING / MITSUBISHI CORPORATION / JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 370/03)

1. On 19 September 2022 the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — FEV Consulting GmbH (‘FEV’, Germany), controlled by FEV Group GmbH (‘FEV Group’, Germany), — Mitsubishi Corporation (‘MC’, Japan), — A newly created company (‘Target JV’, Japan). FEV and MC will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Target JV. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are the following: — FEV: management consultancy services, — MC: trading company which develops and operates business across a variety of industries.

3. Target JV will be active in providing consulting and other services to material manufacturers in Japan.

4. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

5. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10902 – FEV CONSULTING / MITSUBISHI CORPORATION / JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10895 – ATHORA / AXA CUSTOMER SOLUTIONS)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 393/07)

1. On 5 October 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Athora Holding Ltd. (‘Athora’, Bermuda), ultimately controlled by Apollo Global Management, Inc. (‘Apollo’, US), — Axa Customer Solutions Aktiengesellschaft (‘Axa Customer Solutions’, Germany), ultimately controlled by AXA S.A. (France). Athora will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Axa Customer Solutions. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — Athora is active in insurance and reinsurance, mainly in the Netherlands, Belgium, Italy and Germany. Athora is controlled by Apollo, a global alternative asset manager, — Axa Customer Solutions is active in life insurance, predominantly in Germany. It holds a closed book life insurance portfolio of deferred annuities and endowments, representing EUR 19 billion in assets under administration.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10895 – ATHORA / AXA CUSTOMER SOLUTIONS Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10889 – CNP / CVA)

(Text with EEA relevance)

(2022/C 388/03)

On 3 October 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10889. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10875 – AXA IM / SWISS LIFE / MORRISON & CO / LYNTIA NETWORKS)

(Text with EEA relevance)

(2022/C 404/10)

1. On 7 October 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — AXA PIE Lux 4 S.à.r.l. (‘AXA’, France), controlled by AXA S.A., — Swiss Life Investment S.à.r.l. (‘SLAM’, Switzerland), controlled by Swiss Life Holding AG, — Sorolla Investment Co S.à.r.l. (‘Sorolla’, New Zealand), controlled by H.R.L. Morrison & Co Group Limited Partnership (‘Morrison’), — Gunalta ITG, S.L.U. (‘Lyntia’, Spain), controlled by Antin Infrastructure Partners. AXA, SLAM and Sorolla will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Lyntia. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — AXA is a global insurance group, active in life, health and other forms of insurance, as well as in investment management, headquartered in France, — SLAM is an asset management company that is part of the Swiss Life group, an insurance company listed in Switzerland, and — Sorolla is part of Morrison, an investment company investing on behalf of sovereign wealth funds, pension funds and wholesale investors, headquartered in New Zealand.

3. The business activities of the Target are the following: — Lyntia is a neutral optic fibre operator in the telecommunications market, mainly providing services through optic fibre.

4. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

5. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10875 – AXA IM / SWISS LIFE / MORRISON & CO / LYNTIA Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10833 – FRANKLIN RESOURCES / BNY ALCENTRA GROUP HOLDINGS)

(Text with EEA relevance)

(2022/C 397/04)

On 6 September 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10833. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10904 – CVC / MATICMIND / SIO)

(Text with EEA relevance)

(2022/C 417/01)

On 21 October 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10904. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10827 – SCINTIA / BEIERSDORF)

(Text with EEA relevance)

(2022/C 409/01)

On 7 October 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10827. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10918 – PETRONAS / DURIO / ORIM HOLDING)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 428/09)

1. On 28 October 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — PETRONAS Trading Corporation SDN BHD (‘PETRONAS’, Malaysia), controlled by Petroliam Nasional Berhad (Malaysia), — Durio Invest BV (‘Durio’, The Netherlands), — Orim Holding Ltd (‘Orim’, Malta), currently solely controlled by Durio. PETRONAS and Durio will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Orim. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — PETRONAS, is active in the sale and processing of crude oil and petroleum products in the Middle East, Asia-Pacific and the Far East. This includes the supply of crude oil that is suitable for the production of marine fuels. PETRONAS is further active in the wholesale of marine fuels through ex-wharf supplies to bunkering companies and other marine fuel suppliers from its storage tanks in Malaysia and Singapore, — Durio is the holding company of the founders and current indirect owners of Orim. Durio does not have any direct or indirect activities other than through Orim.

3. The business activities of Orim are the supply of marine fuels and the provision of refuelling of sea-faring vessels mainly in the Amsterdam – Rotterdam – Antwerp region, and in Malta.

4. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

5. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10918 – PETRONAS / DURIO / ORIM HOLDING Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10922 – INTERPARKING SERVIZI / GKSD / JV)

(Text with EEA relevance)

(2022/C 423/03)

On 26 October 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10922. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10893 – QUATTROR / IMTC / MTD)

(Text with EEA relevance)

(2022/C 438/01)

On 25 October 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10893. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10578 – CVC / EKATERRA)

(Text with EEA relevance)

(2022/C 435/02)

On 23 May 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10578. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10905 – IRISH LIFE WELLBEING / CENTRIC HEALTH PRIMARY CARE / CAREPATH CONNECT)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 446/10)

1. On 16 November 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Irish Life Wellbeing Limited (‘ILW’, Ireland), — Centric Health Primary Care Limited (‘CH’, Ireland). ILW and CH will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Carepath Connect Designated Activity Company (‘Carepath’, Ireland). ILW and CH are referred to together as ‘the Parties’. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned and the newly set-up joint venture are the following: — ILW is part of the Irish Life Group, which provides life assurance, pensions and wealth management, health insurance and health and wellbeing services in Ireland. It belongs to the Power Corporation of Canada group, an international management and holding company, — CH provides primary healthcare services (general practitioner and specialty) to patients and medical recruitment services to general practitioner practices and hospitals in Ireland. It is part of Rothschild & Co Investment Managers group, a global financial services group, — Carepath will design and implement treatment step plans for primary healthcare, which will aim to improve patients' experience and reduce treatment costs in Ireland.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

5. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10905 – IRISH LIFE WELLBEING / CENTRIC HEALTH PRIMARY CARE / CAREPATH CONNECT Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.